Improved Noninvasive prediction of Liver Fibrosis by Liver Stiffness Measurement in Patients with Nonalcoholic Fatty Liver Disease Accounting for Controlled Attenuation Parameter Values
Citations
780 citations
640 citations
428 citations
319 citations
138 citations
References
8,253 citations
"Improved Noninvasive prediction of ..." refers background or methods in this paper
...Regarding histology, data from the literature((20)) and from our group((31)) clearly show that overall interobserver agreement for staging severe fibrosis in NAFLD is good; and again different relevant studies assessing FibroScan in histologically defined NAFLD were based on multicenter cohorts....
[...]
...The Kleiner classification((20)) was used to stage fibrosis from 0 to 4....
[...]
6,746 citations
"Improved Noninvasive prediction of ..." refers background or methods in this paper
...This picture makes NAFLD as the most common cause of chronic liver disease((1)) as a dramatically growing risk factor for hepatocellular carcinoma,((2)) as a leading indication for liver transplantation,((3)) and as a condition leaving individuals at increased risk of extrahepatic—mostly cardiovascular—morbidity and mortality....
[...]
...Exclusion criteria were as follows: (1) advanced cirrhosis (Child-Turcotte-Pugh B and C); (2) hepatocellular carcinoma; (3) other causes of liver disease or mixed etiologies (alcohol abuse, hepatitis C, hepatitis B, autoimmune liver disease, Wilson disease, hemochromatosis or alpha-1-antitrypsin deficiency); (4) human immunodeficiency virus infection; (5) previous treatment with immunosuppressive drugs and/or regular use of steatosis-inducing drugs, evaluated by a questionnaire (for example, corticosteroid, valproic acid, tamoxifen, amiodarone); or (6) active intravenous drug addiction or use of cannabis....
[...]
3,117 citations
2,387 citations
2,061 citations
"Improved Noninvasive prediction of ..." refers background or methods in this paper
...Two prospective cohort studies of the natural history of NAFLD patients have clearly shown that the severity of liver fibrosis is the stronger predictor not only of liver-related complications but also of important extrahepatic diseases, including cardiovascular disease and extrahepatic malignancies.((4,5)) Accordingly, the evaluation of liver fibrosis severity has...
[...]
...Exclusion criteria were as follows: (1) advanced cirrhosis (Child-Turcotte-Pugh B and C); (2) hepatocellular carcinoma; (3) other causes of liver disease or mixed etiologies (alcohol abuse, hepatitis C, hepatitis B, autoimmune liver disease, Wilson disease, hemochromatosis or alpha-1-antitrypsin deficiency); (4) human immunodeficiency virus infection; (5) previous treatment with immunosuppressive drugs and/or regular use of steatosis-inducing drugs, evaluated by a questionnaire (for example, corticosteroid, valproic acid, tamoxifen, amiodarone); or (6) active intravenous drug addiction or use of cannabis....
[...]
...This picture makes NAFLD as the most common cause of chronic liver disease((1)) as a dramatically growing risk factor for hepatocellular carcinoma,((2)) as a leading indication for liver transplantation,((3)) and as a condition leaving individuals at increased risk of extrahepatic—mostly cardiovascular—morbidity and mortality.((4,5)) Due to the high prevalence of NAFLD, it is critical to identify those individuals at higher risk of developing both hepatic and extrahepatic complications....
[...]